Q2 2023 · 13F-HR
Cormorant Asset Management, LPholdings as filed
Filed 2023-08-14 · accession 0001583977-23-000003
$1.79B
Reported value
64
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $415.2M | 23.3% | 8,142,100 | Common | SOLE |
| 02290A102 | — | AMBRX BIOPHARMA INC | $158.3M | 8.87% | 9,616,155 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $119.3M | 6.69% | 1,310,000 | Common | SOLE |
| 09077A106 | BMEA | BIOMEA FUSION INC | $78.4M | 4.39% | 3,570,872 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $71.7M | 4.02% | 4,169,179 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $63.2M | 3.54% | 2,000,000 | Common | SOLE |
| 45254E107 | IMRX | IMMUNEERING CORP | $42.6M | 2.39% | 4,204,364 | Common | SOLE |
| 23257D103 | CBAYUSD | CYMABAY THERAPEUTICS INC | $41.6M | 2.33% | 3,800,000 | Common | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $41.4M | 2.32% | 1,500,000 | Common | SOLE |
| 29337E102 | ELVN | ENLIVEN THERAPEUTICS INC | $39.5M | 2.21% | 1,936,133 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $33.2M | 1.86% | 665,000 | Common | SOLE |
| 25056L103 | DSGN | DESIGN THERAPEUTICS INC | $32.4M | 1.82% | 5,150,000 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $30.9M | 1.73% | 1,095,000 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $29.8M | 1.67% | 10,813,246 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $29.0M | 1.62% | 2,612,115 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $28.7M | 1.61% | 2,221,739 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $27.8M | 1.56% | 3,200,000 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $27.8M | 1.56% | 3,082,000 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $26.8M | 1.50% | 1,561,696 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $25.7M | 1.44% | 1,421,422 | Common | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $25.6M | 1.43% | 1,350,000 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $24.4M | 1.37% | 340,000 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $24.0M | 1.34% | 576,373 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $22.8M | 1.28% | 2,946,887 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $20.2M | 1.13% | 850,000 | Common | SOLE |
| 48576A100 | — | KARUNA THERAPEUTICS INC | $17.3M | 0.97% | 80,000 | Common | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $17.3M | 0.97% | 2,353,141 | Common | SOLE |
| 77313F106 | RCKT | ROCKET PHARMACEUTICALS INC | $17.3M | 0.97% | 868,550 | Common | SOLE |
| 05465P101 | AXNX* | AXONICS INC | $16.3M | 0.91% | 322,240 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $14.9M | 0.83% | 130,000 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS N V | $14.7M | 0.83% | 973,614 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $14.1M | 0.79% | 600,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $13.9M | 0.78% | 810,800 | PUT | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $11.8M | 0.66% | 1,000,000 | Common | SOLE |
| 46583P102 | — | IVERIC BIO INC | $11.8M | 0.66% | 300,000 | CALL | SOLE |
| 86150R107 | STOK | STOKE THERAPEUTICS INC | $11.6M | 0.65% | 1,087,807 | Common | SOLE |
| 74006W108 | — | PRAXIS PRECISION MEDICINES I | $10.9M | 0.61% | 9,500,000 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $10.4M | 0.58% | 550,000 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $10.0M | 0.56% | 225,000 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $9.9M | 0.55% | 600,000 | Common | SOLE |
| 53000N108 | LIANY | LIANBIO | $9.7M | 0.54% | 4,250,000 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HLDG INC | $8.6M | 0.48% | 150,000 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $8.3M | 0.47% | 1,000,000 | Common | SOLE |
| 03969K108 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | $7.6M | 0.43% | 800,000 | Common | SOLE |
| G3855L106 | GHRS | GH RESEARCH PLC | $7.0M | 0.39% | 593,043 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $6.6M | 0.37% | 350,000 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $6.1M | 0.34% | 325,000 | Common | SOLE |
| 92673K108 | VIGL | VIGIL NEUROSCIENCE INC | $5.8M | 0.32% | 616,786 | Common | SOLE |
| 04683R106 | AVIR | ATEA PHARMACEUTICALS INC | $5.8M | 0.32% | 1,547,181 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS INC | $5.4M | 0.30% | 115,000 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $4.6M | 0.26% | 612,079 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $3.6M | 0.20% | 39,000 | CALL | SOLE |
| 09077B104 | BCABGBP | BIOATLA INC | $3.5M | 0.20% | 1,181,115 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $3.5M | 0.19% | 561,600 | Common | SOLE |
| 52187K200 | CYPH | LEAP THERAPEUTICS INC | $3.4M | 0.19% | 1,073,046 | Common | SOLE |
| 67576A100 | OCUL | OCULAR THERAPEUTIX INC | $3.3M | 0.19% | 645,000 | Common | SOLE |
| 39536G105 | — | GREENLIGHT BIOSCIENCS HLDS P | $2.7M | 0.15% | 9,188,659 | Common | SOLE |
| 36322Q107 | GLTOUSD | GALECTO INC | $2.6M | 0.14% | 1,020,238 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $2.0M | 0.11% | 81,963 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $933,357 | 0.05% | 392,167 | Common | SOLE |
| 38870X104 | GRPH | GRAPHITE BIO INC | $518,822 | 0.03% | 199,547 | Common | SOLE |
| 41358P106 | — | HARPOON THERAPEUTICS INC | $383,826 | 0.02% | 540,600 | Common | SOLE |
| 04965G109 | BCELUSD | ATRECA INC | $312,676 | 0.02% | 319,057 | Common | SOLE |
| 68570P200 | — | ORCHARD THERAPEUTICS PLC | $133,709 | 0.01% | 25,664 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.